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Background: Chinese Uygur, Kazakh, Mongolian and Han populations represent >90% of the total population of
Xinjiang Uygur Autonomous Region, and their genetic backgrounds, customs, culture, and food consumption are
different. The effect of ethnic differences on cardiovascular disease risk factors (CRFs; hypertension, obesity, diabetes,
dyslipidemia, smoking) can be striking but is rarely studied. We report here the findings of the relationship among
these ethnic groups and their CRFs across the four largest ethnic groups of Xinjiang.
Methods: A cross-sectional survey of representative samples was conducted 2002–2008 in Chinese Uygur, Kazakh,
Mongolian and Han populations (age >30 years; 4,421 Kazakh, 3884 Han, 3,218 Uygur, and 892 Mongolian
individuals) in Xinjiang.
Results: A total of 90.4% of Kazakh, 91.9% of Uygur, 90.4% of Mongolian, 85.1% of Han individuals had at least one
CRF. Clustering of ≥2 or ≥3 of these risk factors was noted in 65.2% or 32.1% of Kazakh, 64.8% or 33.0% of Uygur,
66.9% or 36.5% of Mongolian as well as 62.0% or 28.3% of Han subjects, respectively. Compared with the Han
population, the adjusted odds ratios of ≥1, ≥2, and ≥3 CRFs for Kazakh, Uygur and Mongolian populations were
higher (all P<0.001). The age-standardized prevalence of the clustering of ≥1, ≥2, and ≥3 CRFs in Kazakh, Uygur,
Mongolian, and Han populations was lower than their counterparts in the NHANES Ш study (USA) but higher than
in the InterASIA Study (China).
Conclusions: Ethnic groups living in Xinjiang had striking differences in CRFs. Ethnic-specific strategies should be
developed to prevent cardiovascular disease in different ethnic groups.
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Cardiovascular disease (CVD) is a major public health
problem in “developed” and “developing” countries. It
results in an enormous economic burden to the societies
in these types of countries [1,2]. Hypertension, obesity,
smoking, dyslipidemia, and diabetes mellitus (DM) are
other common cardiovascular disease risk factors (CRFs)
and have a causal role in the pathogenesis of CVD [3,4].* Correspondence: lnanfang@yahoo.com.cn
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reproduction in any medium, provided the orStudies have shown that CRFs tend to cluster, and that
the risk for CVD increases substantially with each add-
itional risk factor [5]. The incidence of CRFs in developing
countries is believed to be low. However, recent evidence
suggests that the prevalence of CRFs has increased in eco-
nomically developing countries whereas it has decreased
in economically developed countries [6-8]. Moreover, the
prevalence of CVD and CRFs varies by region. For ex-
ample, in China, the incidence and mortality rates for
CVD have been noted to be higher in northern regions
compared with those in southern regions [9,10]. Further-
more, Gu et al. found that, compared with southern
regions, the prevalence of CRFs (including hypertension,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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higher in northern regions [11].
The Xinjiang Uygur Autonomous Region is located in
northern China and is at a high altitude. Four major
ethnic groups, Chinese Uygur, Kazakh, Mongolian and
Han, represent >90% of the total population of Xinjiang
(2007 Annual Review of Xinjiang). Their genetic back-
grounds, customs, culture, and food consumption are
different. It is well known that hypertension, obesity,
DM and dyslipidemia are multifactorial disorders influ-
enced by genetic and environmental exposure. Studies
have found striking differences across ethnic groups with
respect to the prevalence of CVD and CRFs in other
parts of the world [12,13]. However, little is known
about the prevalence of CRFs among the four ethnic
groups in Xinjiang. It is not known whether there are dif-
ferences in this prevalence between this region and other
regions in China, or in developed countries such as the
USA. Furthermore, in providing a context for policy plan-
ners and health education programs for different ethnici-
ties, it is important to quantify the proportion of the
population at high risk for CVD in different ethnic groups.
Such data may provide valuable information for the under-
standing of the unique prevalence of risk factors among dif-
ferent ethnic populations. Hence, special preventative
strategies and interventions can be developed to lower the
incidence of CVD in different ethnic groups.
The present study was designed to evaluate ethnic
differences in the clustering of CRFs across the Chinese
Uygur, Kazakh, Mongolian and Han populations of
Xinjiang. It was also designed to quantify the propor-
tion of people who had one or more of certain CRFs
(hypertension, dyslipidemia, DM, current smoking, being
overweight) across these four ethnic groups. In addition,
the prevalence of having ≥1, ≥2, and ≥3 CRFs in the
study was compared with the Chinese population in
general as well as in the International Collaborative
Study of Cardiovascular Disease in ASIA (InterASIA Study)
[11] and the USA population in the Third National Health
and Nutrition Examination Survey (NHANESШ )[14].
Methods
Study population
The study was approved by the Ethics Committee of the
People’s Hospital of Xinjiang (Xinjiang, China). Written
informed consent was obtained from all subjects before
data collection and measurements.
A three-stage stratified sampling method was used
to select representative samples of subjects from the
Kazakh, Uygur, Mongolian, and Han communities in
the Xinjiang Uygur Autonomous Region of China. In
the first stage, Xijiang was stratified into north and
south, as delineated by the Tianshan Mountain. Three
counties were randomly selected from each region:Fuyun, Fukang, and Hefeng in the northern region
and Yutian, Luofu, and Hetian in the southern region.
Areas that were as populated or more populated than
the county’s capital were classified as “urban areas”,
and towns that were less densely populated than the
capital served as “rural areas”. In the second stage,
one street district or township was selected randomly
from each urban and rural area. In the third stage,
individual participants (who were aged >30 years)
were selected for inclusion in all selected areas. Only
one participant was selected from each family.
A total of 15,785 persons were selected randomly from
the 12 primary sampling units and invited to participate.
A total of 13,356 individuals completed the survey and
examination (84.6%). The overall response was similar
among men and women and in urban and rural areas.
Data collection
A set of standardized questionnaires was completed. The
questions were based on: demographics; self-reported his-
tory of stroke, myocardial infarction, and congestive heart
failure; previous diagnosis and treatment of hypertension,
obesity, high blood levels of cholesterol, DM and other dis-
eases; family history of hypertension, DM and stroke; drug
treatment, obesity, or being overweight; education; alcohol
consumption; and cigarette smoking. Cigarette smoking
was defined as having smoked at least one cigarette per day
for one or more years during the participant’s lifetime. Data
collection was conducted in examination centers at local
health clinics in the participant’s residential area. For a few
individuals, the interview and examination were conducted
during a home visit. Data collection was undertaken by
trained and certified physicians who could speak Kazakh,
Uygur, Mongolian and Han languages.
For each participant, blood-pressure measurements were
obtained by a standardized protocol adapted from proce-
dures recommended by the American Heart Association.
Body weight and height were measured by trained obser-
vers following a standard protocol. Hypertension was
defined as a mean systolic blood pressure (SBP) ≥140
mmHg and/or a mean diastolic blood pressure (DBP) ≥90
mmHg and/or self-reported current treatment for hyper-
tension with antihypertensive medication. The body mass
index (BMI) was calculated using the following equation:
BMI ¼ body weight kgð Þ= height mð Þð Þ2
Being overweight was defined as having a BMI ≥24
kg/m2.
Laboratory measurements
Venous blood was drawn from all participants who had
fasted for ≥12 h. Serum was separated immediately and
stored at −80°C. All blood samples were examined
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Hospital of Xinjiang. Serum levels of total cholesterol
(TC), high-density lipoprotein-cholesterol (HDL-c), low-
density lipoprotein-cholesterol (LDL-c), triglycerides
(TGs) and fasting blood glucose (FBG) were obtained by
enzymatic methods. Dyslipidemia was defined as self-
reported current treatment with cholesterol-lowering
medication or having one or more of the following
serum levels: TC ≥5.18 mmol/L, TGs ≥1.7 mmol/L,
HDL-c <1.04 mmol/L, or LDL-c ≥3.37 mmol/L. DM was
defined as having a fasting plasma glucose level ≥7.0
mmol/L and/or self-reported current treatment of DM.
Statistical analyses
All analyses were restricted to participants without a
history of myocardial infarction, stroke, and congest-
ive heart failure, and were standardized to the age
distribution for participants. Participants were also
excluded if they had missing measurements with re-
spect to: height; weight; serum levels of TC, HDL-c,
TG, or LDL-c; FBG; or blood pressure. This left a
final study population of 12,415 subjects. The break-
down of the population was 4,421 Kazakh, 3,884 Han,
3,218 Uygur, and 892 Mongolian individuals.
Data analyses were undertaken using SPSS ver16
(SPSS, Chicago, IL, USA). The distribution of clinical
characteristics among participants stratified by ethnic
groups was analyzed using one-way ANOVA or the chi-
square test. The age-standardized prevalence of the
population with ≥1, ≥2, and ≥3 risk factors of CVD was
determined by ethnic group separately, and the signifi-
cance of the differences across subgroups was compared
with the chi-square test. The adjusted odds ratios (ORs)
and 95% confidence intervals (CIs) of having ≥1, ≥2, and ≥3
major risk factors for CVD compared with having no risk
factors for CVD were determined from multivariate
logistic-regression models that included age, sex, and
ethnicity. After standardization to the age distribution
by the direct method for Chinese populations from
the 2000 Census, the prevalence of having ≥1, ≥2,
and ≥3 CRFs in the Kazakh, Uygur, Mongolian and
Han populations in Xinjiang was compared with the
general Chinese population in the InterASIA Study
and the USA population in the NHANES Ш study by
the Wald χ2 test.
Results
Clinical characteristics
Table 1 details the clinical characteristics of the study par-
ticipants. SBP, DBP, as well as levels of TC and LDL-c,
were significantly higher for Kazakh and Mongolian popu-
lations than for Uygur and Han populations (all P<0.001).
FBG, the BMI, and the prevalence of dyslipidemia and
being overweight were significantly higher for Kazakh,Uygur and Mongolian populations than for the Han
population (all P<0.001). TG levels were significantly
higher for Uygur and Han populations than for Kazakh
and Mongolian populations (P<0.001). HDL-c levels
were significantly lower for the Uygur population than
for Kazakh, Mongolian and Han populations (P<0.001).
Drinking and smoking status was significantly lower for
Uygur and Kazakh populations than for Mongolian and
Han populations (all P<0.001). The prevalence of DM
was significantly higher for the Uygur population than
for Han, Kazakh and Mongolian populations (P<0.001).
Age-standardized prevalence of the clustering of ≥1, ≥2,
and ≥3 CRFs among Kazakh, Uygur, Mongolian and Han
populations
In total, 90.4%, 65.2% and 32.1% of Kazakh, 91.9%,
64.8% and 33.0% of Uygur, 90.4%, 66.9% and 36.5% of
Mongolian, and 85.1%, 62.0% and 28.3% of Han
populations had clustering of ≥1, ≥2, and ≥3 CRFs,
respectively (Figure 1). The age-standardized preva-
lence of the clustering of ≥1, ≥2, and ≥3 CRFs were
significantly lower in the Han population than in the
Kazakh, Uygur and Mongolian populations.
Compared with the Han population, the age- and
sex-adjusted ORs of ≥1, ≥2, and ≥3 CRFs for the
Kazakh population were 1.987, 2.373, and 2.283; for
the Uygur population were 2.212, 2.860, and 2.440;
for the Mongolian population were 2.152, 2.653, and
2.892, respectively (Table 2).
Prevalence of the clustering of CRFs: comparison with the
InterASIA Study (China) and NHANES III Study (USA)
The age-standardized prevalence of ≥1, ≥2, and ≥3 CRFs
in Kazakh, Uygur, Mongolian, and Han populations was
lower than their counterparts in the USA but higher
than those in the InterASIA Study (Table 3).
Discussion
The results of the present study indicated that 90.4% of
Kazakh, 91.9% of Uygur, 90.4% of Mongolian, 85.1% of
Han individuals had at least one of the following CRFs:
hypertension; dyslipidemia; DM; were current smokers;
and were overweight. Clustering of ≥2 or ≥3 of these
CRFs was noted in 65.2% or 32.1% of Kazakh, 64.8%
or 33.0% of Uygur, 66.9% or 36.5% of Mongolian,
and 62.0% or 28.3% of Han subjects, respectively.
Compared with the Han population, the adjusted
ORs of ≥1, ≥2, and ≥3 CVD risk factors for Kazakh,
Uygur and Mongolian subjects were higher.
Several studies have noted the striking differences
across ethnic groups in the prevalence of CRFs and
CVD in other parts of the world [12,13]. A key finding
from the current study was that the Chinese Kazakh,
Uygur, Mongolian and Han populations had distinct
Table 1 The clinical characteristics among participants in XinJiang stratified by ethnic groups
Kazakh Uygur Mongolian Han P
n=4421 n=3218 n=892 n=3884
Age (y) 46.7±11.58 51.4±13.41 47.7±11.07 45.4±12.50 <0.001
Gender (male, %) 42.4 41.9 38.0 50.2 <0.001
SBP (mmHg) * 139.1±28.13 130.0±26.04 137.6±28.44 118.9±19.27 <0.001
DBP (mmHg) * 86.9±15.24 79.4±15.00 88.2±16.52 77.4±11.23 <0.001
BMI (kg/m2) ** 26.3±4.56 26.6±4.46 26.5±4.57 24.5±3.62 <0.001
TC (mmol/L) * 4.77±1.16 4.41±1.30 4.84±1.14 4.70±1.14 <0.001
TG (mmol/L) # 1.19±0.82 1.56±1.26 1.15±0.91 1.47±1.23 <0.001
LDL-c (mmol/L) * 2.97±0.99 2.48±1.12 3.06±1.17 2.50±1.13 <0.001
HDL-c (mmol/L) } 1.22±0.44 1.18±0.46 1.39±0.57 1.59±0.56 <0.001
FBG (mmol/L) ** 5.45±1.35 5.54±2.44 5.73±2.45 5.25±1.99 <0.001
Smoking (%) & 16.6 15.7 27.5 36.1 <0.001
Drinking (%) & 13.7 10.6 24.0 38.3 <0.001
Overweight (%) ** 66.0 70.0 67.5 52.5 <0.001
Dyslipidemia (%) * 68.6 72.1 63.1 49.0 <0.001
Diabetes (%) ## 7.3 19.6 7.5 9.1 <0.001
SBP; systolic blood pressure, DBP; diastolic blood pressure, BMI; body mass index, TC; serum total cholesterol, TG; triglyceride, LDL-c; low-density lipoprotein
cholesterol, HDL-c; high-density lipoprotein cholesterol, FBG; fasting blood glucose, 2HPG; 2-hour postprandial glucose.
The differences between ethnic groups were performed by F test or by χ2 test.
*; significantly higher for Kazakh and Mongolian than Uygur and Han.
**; significantly higher for Kazakh, Uygur and Mongolian than Han.
#; significantly higher for Uygur and Han than Kazakh and Mongolian.
}; significantly lower for Uygur than Kazakh, Mongolian and Han.
&; significantly lower for Uygur and Kazakh than Mongolian and Han.
##; significantly higher for Uygur than Han, Kazakh and Mongolian.
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clustering of CRFs was higher in Uygur, Kazakh and
Mongolian populations than in the Han population even
though the current smoking status was higher in the
Han population. The significantly higher prevalence of
≥1, ≥2, and ≥3 CRFs in Uygur, Kazakh and Mongolian
populations compared with the Han population may be
due to the striking differences across ethnic groups with
regard to the prevalence of hypertension, DM, dyslipide-
mia, obesity and being overweight. After a careful re-Figure 1 Age-standardized prevalence of ≥1, ≥2, ≥3 cardiovascular di
ethnic groups (%). * Significant lower than other populaton (P<0.001). **analysis of the characteristics of participants from the
populations in the present study, it appears that the
Kazakh, Uygur and Mongolian populations had a
higher prevalence of hypertension (53.9%, 40.0%, and
55.9%, respectively), being overweight (66.0%, 70.0%,
and 67.5%, respectively) and dyslipidemia (68.6%,
72.1%, and 63.1%, respectively) compared with the Han
population (hypertension, 33.0%; being overweight,
52.5%; dyslipidemia, 49.0%). The striking differences
across ethnic groups with regard to the prevalence ofsease risk factors among participants in Xinjiang stratified by
Significant higher than other populaton (P<0.001).
Table 2 Adjusted odds ratios ( 95% confidence intervals )
of having ≥1, ≥2, ≥3 Vs. none Cardiovascular disease risk
factors associated with ethnic group
≥1 Risk Factor ≥2 Risk Factors ≥3 Risk Factors
Ethnic
group
Han 1.00 (ref ) 1.00 (ref ) 1.00 (ref )
Kazakh 1.987 (1.734-2.277) 2.373 (2.049-2.747) 2.283(1.926-2.705)
Uygur 2.212 (1.883-2.598) 2.860(2.411-3.393) 2.440 (2.006-2.968)
Mongolian 2.152(1.672-2.769) 2.653 (2.037-3.457) 2.892 (2.152-3.887)
The odds ratios for ethnic grouping are adjusted for age and gender.
Li et al. BMC Public Health 2012, 12:499 Page 5 of 7
http://www.biomedcentral.com/1471-2458/12/499CRFs suggests the need for the development of ethnic-
specific and cost-effective CVD prevention programs
and health services to reduce the prevalence of CRFs
as well as morbidity and mortality from CVD in the
Chinese Uygur, Kazakh, Mongolian and Han popula-
tions in the Xinjiang in China.
With regard to the striking differences across ethnic
groups in the prevalence of hypertension, DM, dyslipide-
mia, obesity and being overweight, the mechanisms
underlying this phenomenon are not clear. It is believed
that different environmental exposures among Chinese
Uygur, Kazakh, Mongolian, and Han ethnic groups may
play an important part. Besides the Han population, the
inhabited area of Chinese Uygur, Kazakh and Mongolian
populations is relatively isolated and fixed. Most Kazakhs
and Mongolians live as herders and reside in the villages
and forests north of Xinjiang, which are cold and semi-
arid, whereas most Uygurs live as farmers in the plains
south of Xinjiang, which are hot and arid. Moreover,
Chinese Uygur, Kazakh and Mongolian share similar
dietary habits. These are characterized by drinking
strong wine, eating more animal fat, with a higher saltTable 3 Age-Standardized prevalence of≥1, ≥2, ≥3
cardiovascular risk factors clustering among Kazakh,
Uygur, Mongolian, Han, Inter ASIA Study (China), and
United States (%)
Groups Cardiovascular risk factors clustering
≥1 ≥2 ≥3
Xinjiang of China
Kazakh 89.3 62.7 30.4
Uygur 91.6 67.8 31.4
Mongolian 89.1 64.5 34.6
Han 83.5 57.0 26.4
Inter ASIA Study
China 80.5 45.9 17.2
NHANES III
United States 93.1 73.0 35.9
Standardized on the basis of the year 2000 age distribution of the Chinese
population.intake (>20 g per day) and consuming less grain, fresh
vegetables, beans, bean products, and unsaturated fatty
acids [15]. In addition to different environmental expo-
sures among Chinese Uygur, Kazakh, Mongolian, and
Han ethnic groups, differences in genetic backgrounds
and gene–environment interactions could also be im-
portant factors underlying the different prevalence of
hypertension [16-19]. A further study between these
CRFs and ethnic-specific genetic susceptibility is needed
to clarify this observation.
There is emerging evidence that the synergistic effect
of CRFs clustering is associated with CVD and a higher
prevalence of cardiovascular events [20-23]. Recent stud-
ies have confirmed that the clustering of these risk fac-
tors has more harmful cardiovascular effects than that
predicted by a single risk factor [21-23]. In those studies,
CVD incidence and all-cause mortality increased substan-
tially in the presence of progressively more risk factors. For
example, using data from the First NHANES Epidemiologic
Follow-up Study, the age-, race-, sex-, and education-
adjusted relative risks of coronary heart disease during 21
years of follow-up in adults with 1, 2, 3, 4 or 5 CRFs
(hypertension, high cholesterol, DM, being overweight, and
current smoking) compared with their counterparts with
none of these CRFs were 1.6, 2.2, 3.1, and 5.0, respectively
[23]. In the present study, the much higher age-
standardized prevalence of having clustering of ≥1, ≥2,
and ≥3 CRFs (hypertension, dyslipidemia, DM, current
smoking, and being overweight) were detected in Chinese
Kazakh (90.4%, 65.2% and 32.1%, respectively), Chinese
Uygur (91.9%, 64.8% and 33.0%, respectively) and Mongo-
lian (90.4%, 66.9% and 36.5%, respectively) subjects, which
suggests that those people were exposed to a higher risk
of CVD. Clearly, more effective prevention efforts target-
ing CRFs are needed in these populations. Also, future
public health interventions need to take into account the
special needs of people living in Xinjiang. Another import-
ant finding was that the age-standardized prevalence of
clustering of ≥1, ≥2, and ≥3 CRFs in Chinese Kazakh,
Uygur, Mongolian and Han populations was higher than
subjects in the InterASIA Study (China) and close to their
counterparts in the USA. This finding indicated that the
clustering of CRFs is increasing at a rapid speed in China
during recent years with the increasing prevalence of
hypertension, DM, dyslipidemia, smoking, obesity and
being overweight. Also, effective population-based inter-
ventions such as smoking cessation, improved diet (reduc-
tion of salt and fat), and increased physical activity can
safely and effectively lower the risk of CVD [24,25]. A
multifaceted and targeted approach aimed at prevention,
detection, and treatment of hypertension, dyslipidemia,
DM, and obesity could substantially reduce the prevalence
of each CRF, CRF clustering, as well as morbidity and
mortality from CVD in Xinjiang.
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its results are based on findings in a large, representative
sample of adult Chinese Kazakh, Uygur, Mongolian and
Han populations. In addition, a high response rate was
achieved, standard protocols and instruments were used,
the training and certification requirements for data col-
lection were strict, and a vigorous quality-assurance pro-
gram ensured that high-quality data were collected. Co-
existence of different ethnic populations is common in
many countries. Their genetic background, lifestyle, and
environmental exposures have extensive impacts on risk
factors and diseases. Elucidating the effects of these fac-
tors and adopting preventive measures will help to re-
duce the occurrence of diseases and improve health.
A limitation of the present study was reliance upon
estimates derived from a cross-sectional study. Cross-
sectional studies do not allow for quantification of the
importance of CRF clustering in the prevalence of CVD.
Nevertheless, a further prospective study could be con-
sidered among this population in the future. Moreover,
physical inactivity was excluded as a CRF in the present
analyses because it is causally involved in the develop-
ment of all the CRFs investigated except for cigarette
smoking. Inclusion of physical inactivity as a risk factor
would have artificially increased the prevalence of CRF
clustering. Finally, we recognize that diversity is present
within each of the four ethnic groups studied, and that the
ethnic differences presented in this study are the results of
complex interactions between genetics, lifestyle, socio-
economic status, provision of healthcare, and reporting.
Further examination of these interactions is necessary.
Conclusions
Despite universal access to healthcare, Chinese Uygur,
Kazakh, Mongolian and Han groups living in Xinjiang
differed markedly in their CRF clustering. These findings
suggest that there may be a need to develop ethnic-
specific and cost-effective strategies for preventing CVD
in Xinjiang. These include strategies for preventing DM
that are targeted specifically to high-risk Uygur popula-
tions, designing obesity-, hypertension- and dyslipidemia-
prevention programs for Uygur, Kazakh and Mongolian
populations, and promoting smoking prevention among
Mongolian and Han populations. These ethnicity-tailored
strategies might help to reduce ethnic disparities in CRFs
and the burden of CVD.
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